Detalhe da pesquisa
1.
Computer Modeling of Diabetes and Its Transparency: A Report on the Eighth Mount Hood Challenge.
Value Health
; 21(6): 724-731, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29909878
2.
Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision model.
Ann Gen Psychiatry
; 11(1): 29, 2012 Nov 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23157721
3.
Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA.
Pharmacoeconomics
; 40(10): 979-988, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881325
4.
The Budget Impact of Increased Use of Febuxostat in the Management of Gout: A US Health Plan Managed Care Pharmacy and Medical Costs Perspective.
Clin Ther
; 38(7): 1710-25, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27269247
5.
Febuxostat in the management of gout: a cost-effectiveness analysis.
J Med Econ
; 19(3): 265-76, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26535593
6.
Evaluation of a patient self-directed mealtime insulin titration algorithm: a US payer perspective.
J Med Econ
; 19(6): 549-56, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-26756804
7.
The evaluation of clinical and cost outcomes associated with earlier initiation of insulin in patients with type 2 diabetes mellitus.
J Manag Care Spec Pharm
; 20(9): 968-84, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25166296